In terms of cellular immunity, encapsulation of the antigen gp100 into CS-NP followed by TCI revealed a higher survival rate of tumor-bearing mice after follicular TCI in comparison to a gp 100 antigen solution (21). The gene discussed is PMEL; the disease is neoplasm.